Enzalutamide in Metastatic Prostate Cancer before ChemotherapyTomasz M. Beer, Bertrand Tombal, Celestia S. Higano et al.|New England Journal of Medicine|2014Cited by 3k
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerMary‐Ellen Taplin, Steven P. Balk|New England Journal of Medicine|1995Cited by 1.3k
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studyHoward I. Scher, Charles L. Sawyers, Tomasz M. Beer et al.|The Lancet|2010Cited by 1.1k
Integrative Clinical Genomics of Advanced Prostate CancerDan R. Robinson, Susana Miranda, Eliezer M. Van Allen et al.|Cell|2015Cited by 576
Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice GuidelineD.A. Loblaw, Howard I. Scher, Katherine S. Virgo et al.|Journal of Clinical Oncology|2007Cited by 556